NMTC - NeuroOne Medical Technologies Corporation

Other OTC - Other OTC Delayed Price. Currency in USD

NeuroOne Medical Technologies Corporation

10901 Red Circle Drive
Suite 150
Minnetonka, MN 55343
United States

Full Time Employees3

Key Executives

NameTitlePayExercisedYear Born
Mr. Mark ChristiansonVP of Bus. Devel. & Marketing194.18kN/A1967
Mr. David A. RosaCEO, Pres & DirectorN/AN/A1964
Mr. Steven MertensChief Technology OfficerN/AN/A1963
Mr. Scott HeulerVP of SalesN/AN/A1964
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


NeuroOne Medical Technologies Corporation, an early-stage medical technology company, focuses on the development and commercialization of thin film electrode technology. The company develops cortical and sheet and depth electrode technology to provide continuous electroencephalogram and stereoelectroencephalography recording, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and other related brain related disorders. The company is based in Minnetonka, Minnesota.

Corporate Governance

NeuroOne Medical Technologies Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.